Karsten Voermann - 08 Jan 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Jan 2025, 18:43:26 UTC
Prior SEC filing
09 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gracye Cheng, Attorney-in-Fact for Karsten Voermann

Key filing fact

Karsten Voermann filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 08 Jan 2025.

Key facts

  • This page summarizes Karsten Voermann's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 Jan 2025, 18:43.

Change

  • Previous filing in this sequence was filed on 09 Dec 2024.
  • Current net transaction value: -$128,044.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+89,292
Change %
+29%
Price
Shares after
392,596
Date
08 Jan 2025
Ownership
Direct
Footnotes
F1
GDRX transaction

Class A Common Stock

Tax liability

Transaction value
$128,044
Shares
-29,035
Change %
-7.4%
Price
$4.41
Shares after
363,561
Date
08 Jan 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GDRX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-89,292
Change %
-25%
Price
$0.000000
Shares after
267,876
Date
08 Jan 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
89,292
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Footnote F2

The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .